top of page

Jul 17, 2023

Korro Bio CEO on RNA editing and the process behind reverse mergers

Ram Aiyar discusses RNA editing and the news announced Friday that his company Korro Bio is aiming to do a reverse merge to go public.

Recent Posts

Seoul and Gaithersburg based D&D Pharmatech is leveraging its expertise in peptide engineering for metabolic, fibrotic, and CNS conditions - including a handful of oral GLP-1 based medicines

BridgeBio Founder and CEO Neil Kumar discusses the approval of Attruby and the company's commercialization plans

Led by a longtime leader of Korea's biotech sector, GI Innovation has science-forward programs such as fusion proteins that aim to redefine IL-2 and an IgE trap that could go up against Xolair

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh

bottom of page